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The effect of FK 506 on regeneration of the liver was 
studied in rats after a two-thirds partial hepatectomy 
after 60 min of ischemia of the unresected liver. The 
animals were divided into three distinct groups of 10 
rats each. Group 1 (controls) received 0.5 ml saline 
solution intravenously 30 min after the induction of 
ischemia. Groups 2 and 3 were injected with FK 506 (0.3 
mg/kg) intravenously 30 min after and 24 min before 
the induction of hepatic ischemia, respectively. The 
hepatic content of ATP and serum levels of AL T and 
lactate dehydrogenase were determined on each 
animal. In addition, the histological appearance and 
mitotic activity of the remnant liver was determined at 
regular 24-hr intervals after hepatic ischemia. All 10 
control animals died within 72 hr. Treatment with FK 
506 resulted in improved survival in groups 2 and 3 
(30% and 80%, respectively). The improved survival 
seen in the FK 506-treated animals was reflected by a 
restoration of hepatic ATP content, a reduction in the 
serum levels of AL T and lactate dehydrogenase, an 
amelioration of hepatic necrosis and neutrophilic 
infiltration and an increase in the mitotic activity of 
the liver. These results suggest that FK 506 ameliorates 
the hepatic injury associated with ischemia/reper-
fusion and has a potent stimulatory effect on liver cell 
regeneration that may make it valuable as a hepato-
protective agent when administered to organ donors 
before graft harvesting. (HEPATOLOGY 1991;13:947-951.) 
In recent years, orthotopic liver transplantation 
(OLT) has been accepted as a reasonable therapy for 
patients with end-stage liver disease (1). However, the 
allograft liver is subject to a variety of insults as a result 
of ischemia experienced during the organ harvest, 
reperfusion at the time of organ engraftment, and 
eventually as part of the recipient's immunological 
response to the allograft after transplantation. The 
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ability of the liver to withstand these injuries and then 
to regenerate and regulate its ultimate size is crucial 
after clinical liver transplantation. 
Recently, it has been reported that FK 506 (FK), in 
addition to being a powerful immunosuppressive agent, 
is also hepatotrophic agent (2, 3). To further clarify this 
issue, this study was performed. Specifically the efficacy 
of FK in protecting the liver against the injury associated 
with ischemia/reperfusion in rats subjected to a two-
thirds hepatectomy after 60-min of ischemia was ex-
amined. 
MATERIALS AND METHODS 
Surgical Procedure. Adult male Lewis rats weighing be-
tween 200 and 300 gm were used in the study. Anesthesia was 
induced using ether and was maintained with inhalation of 
metofane. Through a midline abdominal incision a 60-min 
period of ischemia of the right lateral lobe of the liver was 
induced by placing noncrushing microvascular clamps around 
the appropriate branches of the portal vein and hepatic artery 
using an operative microscope. On releasing the clamps and 
restoring blood flow to the right lateral lobe, the median and 
left lateral lobes of the liver were excised according to the 
method of Higgins and Anderson (4). This technique avoids 
total occlusion of the portal vein and hepatic artery during 
experimental hepatic ischemia, leading to splanchnic pooling of 
blood and death of the animal, which is unrelated to the 
ischemic injury produced (5, 6). The animals were allowed to 
recover spontaneously, and subsequent survival was deter-
mined at 12-hr intervals for 7 days. 
All animals used in these studies received humane care as 
defined by The Guide for the Care and Use of Laboratory 
Animals prepared by the National Academy of Sciences and 
published by the National Institutes of Health (NIH Publica-
tions no. 80-23, revised 1978). 
Experimental Protocol. All animals were acclimatized to the 
animal research laboratory for 5 days before being used and 
were allowed free access to food and water both before and 
after the operation. The rats so prepared were assigned to one 
of three different experimental groups (10 rats each). Group 1 
animals were injected intravenously with 0.5 ml saline solution 
and served as the controls. Group 2 animals received FK (0.3 
mg!kg) through the inferior vena cava 30 min before hepatic 
reperfusion. Group 3 animals were injected intravenously with 
FK (0.3 mglkg) 24 hr before induction of the experimental 
hepatic ischemia. 
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FIG. 1. Survival time course of the animals studied. 
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FIG. 2. Hepatic ATP content (f-Lmol/gm dry liver weight) in the 
animals studied. Points represent mean level and brackets indicate 
S.E.M. 
In the second experiment, five to six rats in each of the three 
groups already described were killed at 24-hr intervals, 
beginning from time 0 (end of surgical procedure) and ending 
with 72 hr postoperatively. Immediately before the animals 
were killed, blood samples were taken from the inferior 
vena cava for biochemical analysis. At the same time a portion 
of the remnant liver was removed under freeze-clamping using 
liquid nitrogen for determination of the ATP content. All 
specimens were kept at - 700 C until the time of analysis. 
Another portion of the remnant liver was removed for 
histological examination and counting the number of mitoses. 
Biochemical Analyses. For each rat, serum AL T levels and 
lactate dehydrogenase (LDH) levels were determined using 
standard laboratory methods and Sigma diagnostic kits (Sigma 
Chemical Co., St. Louis, MO). Measurement of the ATP 
content in the liver was accomplished using the methods of 
Bergmeyer (7). A weighed portion of the frozen liver was 
ground in liquid nitrogen in 5 vol precooled 4% perchloric acid 
(wt/vol), and the mixture was thoroughly homogenized using 
a precooled polytron homogenizer (Beckman Instruments, 
Fullerton, CA). The resultant sample was centrifuged at 
3,000 rpm for 10 min at 40 C. The supernatant was removed 
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FIG. 3. Serum ALT (U/m!) levels in animals studied. Points 
represent mean level and brackets indicate S.E.M. 
respun at 3,000 rpm for 5 min at 40 C. The hepatic ATP content 
was quantitated enzymatically using ultraviolet spectropho-
tometry and a Sigma diagnostic kit. 
Histological Examination. Liver specimens were fixed in 
10% formalin, dehydrated, embedded in paraffin, cut at 5 iJ-m 
and stained for histological examination with hematoxylin and 
eosin. The number of mitoses, as an index of hepatocyte 
regeneration, was determined/l0 high-power field, and the 
extent of any liver necrosis and hepatocyte damage was 
estimated semiquantitatively on a 0 to 3 + scale. 
Statistical Analysis. Data are reported as mean 
values ± S.E.M. Mean values were compared using ANOVA 
and the Tukey multiple comparison procedure. The X2 test 
with Yates' correction was used to test for differences in 
proportions. A p value of < 0.05 was considered to be 
statistically significant. 
RESULTS 
The 7 -day survival rate for each of the three groups of 
animals studied is shown in Figure 1. AB may be seen, all 
group 1 controls died within 72 hr. The survival in the 
animals receiving 0.3 mg/kg FK 30 min before reper-
fusion in group 2 was 30%. In contrast, the survival for 
group 3 animals receiving the same dose of FK CO.3 
mg/kg) but administered 24 hr before the induction of 
hepatic ischemia was 80% (p < 0.01). 
At each time interval studied, the concentration of 
ATP in the reperfused ischemic remnant of the liver was 
significantly higher in both groups of rats receiving FK 
than in the group 1 control animals (p < 0.05). Fur-
thermore, as may be seen in Figure 2, in group 3 the ATP 
content reached the preischemic value within 24 hr 
postoperatively and was maintained at that level 
through 72 hr; in group 2 rats, ATP content reached 
preischemic levels by 72 hr. 
Serum ALT values in all groups of animals studied 
increased after the ischemia, peaked at 24 hr and 
declined thereafter. Statistically significant differences 
were found between groups 2 and 3 at 0 and at 48 hr 
postoperatively, with lower ALT values seen in the 
FK-pretreated group 3 animals (p < 0.05) (Fig. 3). 
As illustrated in Figure 4, the values for LDH 
increased markedly in all groups studied immediately 
after ischemia (0 hr) but declined thereafter only in the 
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FIG. 4. Serum LDH (UIL) levels in animals studied. Points represent 
mean level and brackets indicate S.E.M. 
rats that received FK (groups 2 and 3). The LDH level 
was significantly lower in the group 3 animals that were 
pretreated with FK 24 hr before induction of ischemia as 
compared with the controls both at 24 and 48 hr after 
ischemia (p < 0.05). 
The degree of hepatic necrosis in each group of 
animals studied is presented in Figure 5. In all groups 
the greatest degree of necrosis was seen at 24 hr after 
ischemia when the transaminase levels also reached 
their maximal value. However, the animals treated with 
FK (groups 2 and 3) had lower levels than did those in 
the control group. At 48 hr, the extent of hepatic necrosis 
was less in the group 3 animals as compared with both 
the animals in groups 1 and 2. 
The mitotic activity present within the. liver remnant 
reached a maximal level 48 hr after the ischemic period 
in the control group and the FK-treated animals. The 
mitotic activity in the group 3 animals increased further 
on the third day (72 hr) and achieved a peak. value that 
was double the level seen in the group 2 animals at 72 hr. 
This difference was statistically significant (p < 0.02) 
(Fig. 6). 
The histological alterations present in representative 
livers are illustrated in Figure 7. In the control group 
(group 1), extensive necrosis with neutrophilic infil-
tration was seen 24 hr after ischemia (Fig. 7 A). The 
residual parenchymal cells were swollen, had cyto-
plasmic vacuoles and demonstrated nuclear pyknosis. At 
24 and 48 hr, increased mitotic activity was evident in 
the control rat hepatocytes that escaped necrosis (Fig. 
7B). In contrast, in rats treated with FK (groups 2 and 
3) a lesser degree of hepatic necrosis was seen at 24 hr 
postoperatively as shown in Figure 7C. Moreover, the 
specimens obtained showed a higher mitotic activity in 
the hepatocytes of group 3 at 48 hr compared with 
groups 1 and 2 (Fig. 7D). The histological changes in the 
number of viable hepatocytes in the FK-treated groups 
were quite similar to those in the control group, but 
these changes occurred to a lesser degree and with 
minimal or absent neutrophilic infiltration, particularly 
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FIG. 6. Number of mitoses/l0 high-power field in the animals 
studied across time. 
DISCUSSION 
Recent improvement in patient survival has resulted 
in the widespread application of OLT as a reasonable 
therapy for end-stage liver disease (8). Attempts to 
prevent or to diminish the allograft injury associated 
with organ harvesting, reperfusion and rejection have 
already involved the use of several different pharmaco-
logical agents. Recently, experimental studies obtained 
in animals have focused considerable attention on the 
hepatotrophic activities of cyclosporin A (9-14) and FK 
(2, 3, 15), two potent immunosuppressive agents cur-
rently being used after clinical OLT. 
In this study, rats were subjected to a standard 
two-thirds hepatectomy after 60-min of ischemia of the 
unresected right hepatic lobe. The regenerative response 
of the residual ischemic right hepatic lobe was therefore 
critical for subsequent animal survival. 
Pretreatment of the rats with FK at a dose of 0.3 
mg/kg, 24 hr before the induction of the experimental 
ischemia (group 3) had a survival rate of 80% at 24 hr 
that was maintained through the subsequent 7 days 
(Fig. 1). The ATP content in the liver of these same 
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FIG. 7. Histological appearance of representative livers obtained from animals studied. (A) Medium-power photomicrograph of hepatic lobule 
in group 1 animal. Wide swaths of coagulative necrosis are infiltrated by neutrophils. Residual preserved hepatocytes extend into the center of 
the field (H & E, original magnification x 100). (B) Residual hepatocytes in group 1 animal. Single mitosis is identified in the center of the 
photograph. Other animals in this group had higher mitotic activity (H & E, original magnification x 250). (e) Lobular field from group 3 animal. 
Even at this power, sublethal hepatocyte damage in the form of cytoplasmic vacuolization is observed. However, no overt necrosis is seen 
(H & E, original magnification x 100). (D) Brisk mitotic activity is seen in hepatocytes from this group 3 animal (H & E, original magnification 
x 250). 
animals was restored at 24 hr and was maintained for 
the subsequent 72 hr (Fig. 2). A similar strong associ-
ation between postischemic hepatic ATP content and 
subsequent recovery has been demonstrated in other 
models of hepatic (16) and renal (17) ischemia. The 
improved survival of the group 3 animals pretreated 
with FK 24 hr before the initiation of ischemia was 
reflected also by lower serum levels of AL T (Fig. 3) and 
LDH (Fig. 4) and by an amelioration of the liver necrosis 
(Fig. 5) and neutrophilic infiltration produced as a result 
of the ischemia as compared with the saline-treated 
controls. Moreover, the mitotic activity of the residual 
hepatocytes in the FK-treated animals was greater than 
that seen in the saline-treated control group (Fig. 7). 
A link between the immune system and hepatic 
regeneration has been reported recently (11, 12, 18-21). 
It is therefore of some considerable interest to determine 
the precise relationship between the status of the 
immune system and subsequent hepatic regeneration. 
In the present model the immune system is activated by 
both the two-thirds partial hepatectomy (22-25) and the 
experimental hepatic ischemia (12). Structural alter-
ations of the surface of hepatocytes caused by the 
ischemic injury presumably initiate a cytotoxic immune 
reaction against autologous hepatocytes. It is also 
possible that the activated immune system has an 
independent inhibitory effect on hepatocyte cell mitosis 
and that this action is unmasked by the powerful T 
cell-specific immunosuppression exhibited by both cy-
closporin A and FK. In agreement with this latter 
hypothesis is the observation of Takahashi, Takeshita 
and Yokomuro (26) that activated lymphocytes exert an 
important effect in suppressing hepatocyte division. 
Additionally, liver regeneration recently has been con-
ceptualized as a phenomenon regulated !by T lympho-
cytes (27, 28). In fact, regeneration is inhibited rather 
than enhanced by nonspecific immunosuppressive 
agents such as azathioprine (29) and glucocorticoids 
(30). 
Another possible mechanism for the beneficial effect 
of FK in terms of the effects herein observed is that by 
inhibiting interleukin-2 production and binding (31,32), 
FK impairs the secretion of liver regulatory factors, 
either by an as yet unknown immune mechanism (15) or 
possibly by pathways that are not connected with the 
immune system at all (2). 
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It is of some interest to mention that in this work, 
FK-treated rats showed minimal or absent neutrophilic 
infiltration compared with control animals. This effect 
may contribute to the efficacy of FK in enhancing the 
regenerative response and recovery of the experimental 
animals because these cells release oxygen free radicals 
and other materials that can injure liver cells and 
thereby impair their regeneration. 
From a clinical point of view, perhaps one of the most 
promising strategies for the amelioration of the reper-
fusion injury after organ engraftment is reduction of 
oxygen free radical production (33, 34). It is currently 
unknown whether FK inhibits the generation of oxy-
gen free radicals by granulocytes or by activated en-
zymes within the ischemic tissue. Either action would 
be likely to enhance graft function after transplanta-
tion (35). 
Based on these data, it can be concluded that FK 
maintains hepatic ATP levels and reduces cytosolic 
enzyme loss after hepatic ischemia. Furthermore, it 
appears to reduce the subsequent hepatic necrosis and 
neutrophilic infiltration and to stimulate hepatocyte 
proliferation. As a result, the liver is able to recover and 
subsequent survival is enhanced. 
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